1-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-indole-3-carbaldehyde

Catalog No. :
ACXRAW977
CAS No. :
338770-32-4
Molecular Formula :
C15H8ClF3N2O
Molecular Weight :
324.69

IUPAC Name:1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-indole-3-carbaldehyde

1-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-indole-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$124.00Login to see priceInquiryInquiry
250mg95%$279.00Login to see priceInquiryInquiry
1g95%$416.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-indole-3-carbaldehyde
IUPAC Name1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-indole-3-carbaldehyde
Molecular FormulaC15H8ClF3N2O
Molecular Weight324.69
SMILESO=CC1=CN(C2=NC=C(C(F)(F)F)C=C2Cl)C3=C1C=CC=C3
InChI KeyVAXNPSOTXPROHH-UHFFFAOYSA-N
Synonym1-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-indole-3-carboxaldehyde 97%;1-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-3-formyl-1H-indole, 3-Chloro-2-(3-formyl-1H-indol-1-yl)-5-(trifluoromethyl)pyridine;1-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-indole-3-carboxaldehyde97%;1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-indole-3-carbaldehyde;1H-Indole-3-carboxaldehyde, 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-
CAS No.338770-32-4

Synthetic Route by SureRoute

1. ACXRAW977 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXRAW977 route product structure diagram
    ACXRAW977338770-32-4
Inquiry

2. ACXRAW977 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXRAW977 route product structure diagram
    ACXRAW977338770-32-4
Inquiry

Comments (0)